MedPath

The influence of therapeutic inorganic iodine for Graves' disease on long-term prognosis.

Not Applicable
Conditions
Graves&#39
disease
Registration Number
JPRN-UMIN000047660
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
56
Inclusion Criteria

Not provided

Exclusion Criteria

(1) A patient is treated with anti-thyroid drugs except inorganic iodine. (2) A patient is not pregnant woman or lactating woman or expected pregnancy within recent 2 years. (3) A patient has uncontrolled Graves' disease or untreated heart disease. (4) A patient has already treated with radioiodine or surgery. (5) A patient is inappropriate for present study by judging from the manager of the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath